|LETTER TO EDITOR
|Year : 2023 | Volume
| Issue : 1 | Page : 97
The role of artificial intelligence in the development of COVID-19 vaccine
Sattari Mohammad1, Mohammadi Maryam2
1 Health Information Technology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Management and Health Information Technology, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||24-Jul-2021|
|Date of Decision||17-Aug-2021|
|Date of Acceptance||09-Sep-2021|
|Date of Web Publication||27-Jul-2023|
Department of Management and Health Information Technology, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Mohammad S, Maryam M. The role of artificial intelligence in the development of COVID-19 vaccine. Int J Prev Med 2023;14:97
The coronavirus disease-2019 (COVID-19) pandemic is a phenomenon that has infected and killed many people in many countries. Vaccination has been suggested as a good way to fight COVID-19, and it is certainly important to design a safe and effective vaccine. In the healthcare system, artificial intelligence (AI) is emerging as an effective tool. The use of AI in diagnosing various health conditions and interpreting complex medical issues is very significant. AI capabilities can be used as an effective tool to study SARS-CoV-2 and its capabilities, virulence, and genome. For example, machine learning techniques such as neural networks and support vector machines can be used to identify antigens from protein sequences. Epidemic progression can also be tracked and patients monitored. Thus, AI accelerates research into the treatment of COVID-19.
In a study conducted in Canada, a drive-through method which is a hybrid model consisting of a discrete event and an agent-based simulation was proposed as one of the effective temporary mass vaccinations among other methods. In this study, a machine learning model was presented which is based on a large data set derived from 125,000 runs of a drive-through mass vaccination simulation tool. The results show that this model can well predict the main outputs of the simulation tool. Thus, this model has become an online application that can help mass vaccination planners to more quickly evaluate the results of a variety of mass vaccination facilities. Researchers in China have developed a deep learning-based drug screening method for novel coronavirus using Dense Convolutional Network (DenseNet) to predict interactions between proteins and ligands. This method helps predict which drug compounds will respond preferably well to the virus. In a study conducted in the USA, potential COVID-19 vaccine candidates were predicted using the Vaxign-ML reverse vaccination machine learning platform, which relied on supervised classification models. The results showed that the predicted vaccine targets have the potential to produce an effective and safe COVID-19 vaccine. A study was also conducted in the United Kingdom with the aim of training deep learning Recurrent Neural Networks (RNNs) to produce simulated spike protein sequences. In this study, RNNs were trained to present computer-simulated coronavirus spike protein sequences in the style of previously known sequences and to investigate their characteristics. This approach may provide a possible alternative to identifying vaccine design targets by creating spike sequences.
Thus, for AI technology to be used in vaccine development, more attention needs to be paid to data collection in this area. In fact, by recording various data that represent the performance of the vaccine or information about proteins and interactions between them, space can be provided for the use of AI and machine learning techniques. Various solutions can be suggested. The first solution is to use simulation software, because this software can produce and evaluate large amounts of data at a very low cost. The second solution is to discuss proteins and the interactions between them. In this case, too, machine learning techniques can be used to predict these interactions.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kannan S, Subbaram K, Ali S, Kannan H. The role of artificial intelligence and machine learning techniques: Race for COVID-19 vaccine. Arch Clin Infect Dis 2020;15.
Asgary A, Valtchev SZ, Chen M, Najafabadi MM, Wu J. Artificial intelligence model of drive-through vaccination simulation. Int J Environ Res Public Health 2021;18:1-10.
Huang G, Liu Z, Van Der Maaten L, Weinberger KQ. Densely connected convolutional networks. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition. 2017. p. 2261-9.
Ong E, Wong MU, Huffman A, He Y. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Front Immunol 2020;11:1581.
Crossman LC. Leveraging deep learning to simulate coronavirus spike proteins has the potential to predict future zoonotic sequences. bioRxiv April 2020:2020.04.20.046920. doi: 10.1101/2020.04.20.046920.